Crystallographic, thermal and spectroscopic characterization of a ciprofloxacin saccharinate polymorph

International Journal of Pharmaceutics

Volumn 391, Issue 1-2, 2010, Pages 197-202

  Romanuk C B ^a   Garro Linck, Y ^a   Chattah, A K ^a   Monti, G A ^a   Cuffini, S L ^b   Garland, M T ^c   Baggio, R ^d   Manzo, R H ^a   Olivera, M E ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Centro de Excelencia en Productos y Procesos de Cordoba   (Argentina)

^c CIMAT   (Chile)

^d DEPARTAMENTO DE FÍSICA   (Argentina)

Author keywords

Fluoroquinolone; Polymorphism; Salts; Solid state characterization

Indexed keywords

CIPROFLOXACIN; CIPROFLOXACIN SACCHARINATE I; CIPROFLOXACIN SACCHARINATE II; SACCHARIN SODIUM; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DETERMINATION; DRUG STRUCTURE; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; POWDER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SOLID STATE; STRUCTURE ANALYSIS; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY DIFFRACTION;

EID: 77952886477     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.007     Document Type: Article

References (24)

1. Banerjee R., Bhatt P.M., Ravindra N.V., Desiraju G.R. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities. Cryst. Growth Des. 2005, 5:2299.
2. Baran E.J. The saccharinate anion: a versatile and fascinating ligand in coordination chemistry. Quim. Nova 2005, 28:326.
3. Bennet A.E., Rienstra C.M., Auger M., Lakshmi K.V., Griffin R.G.J. Heteronuclear decoupling in rotating solids. Chem. Phys. 1995, 103:6951.
4. Bernstein J., Davis R.E., Shimoni L., Chang N.L. Patterns in hydrogen bonding: functionality and graph set analysis in crystals. Angew. Chem. Int. Ed. Engl. 1995, 34:1555.
5. Bhatt P.M., Ravindra N.V., Banerjee R., Desiraju G.R. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities. Chem. Commun. 2005, 28:1073.
6. Binev I.G., Stamboliyska B.A., Velcheva E.A. The infrared spectra and structure of o-sulfobenzimide (saccharin) and of its nitranion: an ab initio force field treatment. Spectrochim. Acta A 1996, 52:1135.
7. Breda S.A., Jimenez Kairuz A.F., Manzo R.H., Olivera M.E. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. Int. J. Pharm. 2009, 371:106.
8. CCDC 737186 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif.
9. Chattah A.K., Garro Linck Y., Monti G.A., Levstein P.R., Breda S.A., Manzo R.H., Olivera M.E. NMR and IR characterization of the aluminium complexes of norfloxacin and ciprofloxacin fluoroquinolones. Magn. Reson. Chem. 2007, 45:850-859.
10. Clinical Pharmacology, 2007. Ciprofloxacin [Internet, Restricted Access]. Clinical Pharmacology A Gold Standard Product An Elsevier Company (cited 2009 July 10). Available from: http://clinicalpharmacology.com/Forms/drugoptions.aspx%3Fcpnum=127%26n=Ciprofloxacin.
11. Fallati C.S., Ahumada A.A., Manzo R.H. El Perfil de Solubilidad de la Ciprofloxacina en Función del pH. Acta Farmacéut. Bonaerense 1994, 13:73.
12. Harris R.K. Nuclear Magnetic Resonance Spectroscopy 1994, Longman Scientific and Technical, London, UK.
13. Hee-Kim E., Hoo-Kyun C. Preparation of various solid-lipid beads for drug delivery of enrofloxacin. Drug Deliv. 2004, 11:365.
14. Hooper D.C., Wolfson J.S. Quinolone Antimicrobial Agents 1993, American Society for Microbiology. 2nd ed.
15. Manzo, R.H., Olivera, M.E., Romañuk, C.B., Universidad Nacional de Córdoba, 2009. Procedimiento para Obtención de Sacarinatos de Antimicrobianos Fluoroquinolónicos y los Sacarinatos Obtenidos. Córdoba, Argentina. Solicitud de patente P-060105581, 18/12/06. Publicada 11/02/09, Boletín N° 516, p. 4. ISS N 0325-6545. Instituto Nacional de la Propiedad Industrial.
16. Pisal S., Zainnuddin R., Nalawade P., Mahadik K., Kadam S. Molecular properties of ciprofloxacin-indion 234 complexes. AAPS Pharm. Sci. Technol. 2004, 22 5:1.
17. Romañuk C.B., Garro Linck Y., Chattah A.K., Monti G.A., Manzo R.H., Olivera M.E. Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones. J. Pharm. Sci. 2009, 98:3788.
18. Shirai Y., Sogo K., Fujioka H., Nakamura Y. Role of low-substituted hydroxypropylcellulose in dissolution and bioavailability of novel fine granule system for masking bitter taste. Biol. Pharmaceut. Bull. 1994, 17:427.
19. Takács-Novák K., Noszal B., Hermecz I., Kereszturi G., Podanyi B., Szasz G. Protonation equilibria of quinolone antibacterials. J. Pharm. Sci. 1990, 79:1023.
20. Turel I. The interactions of metal ions with quinolone antibacterial agents. Coord. Chem. Rev. 2002, 232:27.
21. Turel I., Bukovec P., Quirós M. Crystal structure of ciprofloxacin hexahydrate and its characterization. Int. J. Pharm. 1997, 152:59.
22. Velaga S.P., Basavoju S., Boström D. Norfloxacin saccharinate-saccharin dihydrate cocrystal-a new pharmaceutical cocrystal with an organic counter ion. J. Mol. Struct. 2008, 889:150.
23. Wardell J.L., Low J.N., Guidewell C. Saccharin, redetermined at 120K: a three-dimensional hydrogen-bonded framework. Acta Cryst. 2005, E61:1944-1946.
24. 2]. Polyhedron 2001, 20:3209.